Cancer treatment continues to evolve rapidly, bringing new therapies that are more targeted, more personalized, and often more effective than traditional approaches. One of the newest advancements gaining attention is bispecific therapy, an innovative type of immunotherapy that is beginning to change how certain cancers are treated.
At Cancer Specialists of North Florida, we recently expanded access to bispecific therapy in Clay County, allowing patients to receive this advanced treatment closer to home for the first time. For many patients and families, that access can make a meaningful difference during an already difficult time.
Bispecific therapies work differently from traditional chemotherapy. Chemotherapy attacks rapidly dividing cells throughout the body, including some healthy cells, which can lead to significant side effects. Bispecific therapy takes a more targeted approach by helping the body’s own immune system recognize and attack cancer cells more effectively.
In simple terms, these therapies act like a bridge. One part of the treatment connects to the cancer cell, while the other connects to immune cells within the body. This helps direct the immune system to identify and destroy cancer cells in a more precise way.
Currently, bispecific therapies are being used most commonly for blood cancers such as multiple myeloma and lymphoma, and they are also beginning to show promise in small-cell lung cancer treatment. As research continues, many experts believe therapies like this will become increasingly important in the future of cancer care.
One of the most encouraging aspects of bispecific therapy is the durability of response. In many cases, these treatments can continue working for longer periods of time because they train the immune system to continue recognizing and fighting cancer cells even after treatment has begun.
While every treatment comes with potential side effects and monitoring requirements, these therapies often provide new possibilities for patients whose cancer may not have responded to more traditional treatments.
For patients in Clay County, local access is especially important because bispecific therapy requires close monitoring during the early stages of treatment. Many patients need to come in daily for observation and follow-up care as providers carefully manage side effects and monitor how the body responds.
Before this program became available locally, patients often had to travel 40 minutes to an hour each day to larger facilities in Jacksonville while already feeling physically and emotionally drained from treatment. Being able to receive this level of care closer to home reduces some of that burden for patients and caregivers alike.
Our bispecific therapy program was first launched at our Riverside location and recently expanded to our Clay County office in April. Since then, we have already begun treating patients locally and continue working to expand access across our network of care.
Community oncology practices play an important role in making advanced cancer treatments more accessible outside of large academic medical centers. Patients should not have to leave their communities or travel long distances to receive innovative care when it can safely and effectively be delivered close to home.
As cancer treatment continues to advance, therapies that harness the immune system are creating new opportunities and new hope for patients facing difficult diagnoses. While there is still much work ahead, it is encouraging to see these advancements becoming more widely available within community oncology settings.
Tejas Karawadia, M.D., is a board-certified hematologist and oncologist with Cancer Specialists of North Florida and sees patients in Clay County and Jacksonville. He specializes in treating a wide range of cancers and blood disorders, with a focus on providing personalized, patient-centered care close to home. For more information about Cancer Specialists of North Florida and available treatment options, visit CancerSpecialistsNF.com or call (904) 214-8050.
